Yongjin Holdings regains control of Special Treat Kelly? Wang Chong elected as new Director: Take off the Hat is a key task | Quick read of the announcement.

① Wang Chong has officially been elected as the new chairman of the Special Treat Shanghai Kinetic Medical sixth Board of Directors, filling the vacancy left by Cai Zhongxi's departure. ② Wang Chong responded that the related Trade involving Shanghai Kinetic Medical has been halted, and the urgent matter is to remove the Special Treat label.

cls.cnMay 8 22:32

Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.

① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.

cls.cnApr 26 13:45

Shanghai Kinetic Medical: Disagreement between management and auditors leads to the "delay" of the annual report; the former Director continues to increase Shareholding | Quick announcement

① Due to significant differences between the management and the auditors regarding the audit opinion on the periodic report, Shanghai Kinetic Medical has delayed the disclosure of its annual report. ② Through Shareholding, Shanghai Xincheng Yi and Yuan Zheng, along with their concerted actions, collectively Hold approximately 6.38% of the shares of Shanghai Kinetic Medical, approaching the shareholding ratio of Yongjin Holdings.

cls.cnApr 24 00:17

Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.

In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.

cls.cnApr 7 08:17

Dramatic scene! Shanghai Kinetic Medical is being sued by the chairman's own company, escalating the equity repurchase dispute to judicial contention.

① Shanghai Xinchengyi, controlled by Yuan Zheng, has sued Shanghai Kinetic Medical, chaired by Yuan Zheng, requesting the annulment of the previous Board of Directors resolution; ② Lawyers believe that share buyback is a significant matter for the company, directly affecting the interests of small and medium shareholders, and this lawsuit also sends a signal of corporate governance risk to the market; ③ In the current predicament of Shanghai Kinetic Medical, the protection of small and medium investors' interests is urgent and it is necessary to ensure that the opinions of all shareholders are treated fairly.

cls.cnMar 14 23:58

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 3 10:09